The global alpha 2C adrenergic receptor market is anticipated to grow at a significant CAGR during the forecast period. The alpha 2C adrenergic receptor is a G protein-coupled receptor (GPCR). It is associated with the Gi heterotrimeric G-protein. The major factor accelerating the growth of the market is the increasing prevalence of bipolar disorder across the globe.
According to the National Institute of Mental Health (NIMH), bipolar disorder affects approximately 5.7 million adults or about 2.6% of the population age 18 and older every year in the US. Additionally, the median age for bipolar disorder is 25 years, however, the illness can also start in early childhood or as late as 40-50 years of age. Further, as per the World Health Organization (WHO), epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Hence, the rising prevalence of bipolar disorder is increasing the demand for alpha 2C adrenergic receptors.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on Alpha 2C Adrenergic Receptor Market: https://www.omrglobal.com/request-sample/alpha-2c-adrenergic-receptor-market
Some major players in the market include Johnson & Johnson Services, Inc., and Otsuka Holdings Co Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2021, Otsuka Pharmaceutical Co., Ltd. announced the regulatory approval of REXULTI (brexpiprazole), an orally disintegrating dose (OD) tablet in Japan. Brexpiprazole is a serotonin-dopamine activity modulator (SDAM). It acts as a partial agonist at 5-HT1A and dopamine D2 receptors and an antagonist at 5-HT2A and noradrenaline alpha1B/2C receptors.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Johnson & Johnson Services, Inc., and Otsuka Holdings Co Ltd., among others.
A full Report of Alpha 2C Adrenergic Receptor Market is Available @ https://www.omrglobal.com/industry-reports/alpha-2c-adrenergic-receptor-market
Global Alpha 2C Adrenergic Receptor Market Report by Segment
By Type
- Lacripep
- JNJ-4789
- SKL-PSY
- Others
By Application
- Bipolar Disorder
- Dry Eye
- Major Depressive Disorder
- Others
Global Alpha 2C Adrenergic Receptor Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
